HD-tDCS + Speech Therapy for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how gentle electrical stimulation (targeted transcranial direct current stimulation), combined with speech therapy, aids in recovering language skills after a stroke. Participants will be divided into groups to receive either real or sham electrical stimulation, along with one of two types of speech therapy. The trial targets individuals who have experienced a stroke or similar event affecting language abilities and can speak English. Participants must be comfortable with MRIs and free from certain health conditions, such as severe mental health issues or advanced neurodegenerative diseases. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance recovery options for stroke survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that transcranial direct-current stimulation (tDCS) combined with speech therapy can aid in regaining language skills after a stroke. Studies have found tDCS to be safe, noninvasive, and painless, causing no harm or discomfort during use.
In earlier studies, both regular and high-definition tDCS (HD-tDCS) were well-received. Participants improved in naming objects and answering questions more quickly, indicating that side effects are minor and the treatment is manageable.
Overall, previous research suggests that using HD-tDCS with speech therapy is safe for individuals with language difficulties after a stroke. This combination may enhance speech recovery without causing significant discomfort or harm.12345Why are researchers excited about this trial's treatments?
Researchers are excited about this trial because it explores the combination of HD-tDCS and specialized speech therapy to treat aphasia in a novel way. Unlike traditional speech therapy, which focuses solely on language exercises, HD-tDCS (high-definition transcranial direct current stimulation) uses electrical stimulation to potentially enhance brain plasticity and recovery. This dual approach might offer a more effective rehabilitation by directly targeting brain function while simultaneously engaging language skills. The possibility of synergistic effects between the electrical stimulation and targeted speech therapy is what has researchers intrigued about its potential benefits for those with aphasia.
What evidence suggests that this trial's treatments could be effective for aphasia?
Research has shown that high-definition transcranial direct current stimulation (HD-tDCS) combined with speech therapy can aid in recovering language skills after a stroke. In this trial, participants will be randomized to receive either anodal HD-tDCS or sham-tDCS. Studies have found that HD-tDCS, when paired with speech therapy, enables people to name objects more accurately and quickly than speech therapy alone. This gentle electrical stimulation can enhance naming accuracy and response speed.
Another group in this trial will receive speech therapy, which is also highly effective. Real-world evidence indicates that intensive speech therapy can significantly improve language comprehension and speaking skills. Many patients experience positive changes, especially with 20 to 50 hours of therapy. These findings suggest that both HD-tDCS and speech therapy can aid language recovery after a stroke.13678Are You a Good Fit for This Trial?
This trial is for adults over 18 with aphasia from left-sided brain damage like a stroke, who can speak English and are MRI-eligible. It's not for those with advanced neurodegenerative diseases, unmanaged seizure disorders, severe mental health issues, major hearing or vision problems, developmental disabilities, or MRI contraindications such as metal implants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Cycle A
Participants receive targeted anodal-tDCS or sham-tDCS along with speech therapy for 10 sessions
Assessment and Crossover
Participants undergo behavioral assessment and fMRI before crossing over to receive the alternate tDCS intervention
Treatment Cycle B
Participants receive the alternate tDCS intervention along with the same speech therapy arm for another 10 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment with behavioral assessments and fMRI at 3 and 6 months post Treatment Cycle B
What Are the Treatments Tested in This Trial?
Interventions
- Speech Therapy
- Targeted Transcranial Direct Current Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor